Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Foerster, Ana Martín-Villalba, Kevin Chris Ziegler et al.|Nature Communications|2025Cited by 3
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targetsStefan Wiemann, Ângela Gonçalves|Research Square|2023Cited by 1
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Foerster, Ana Martín-Villalba, Oğuzhan Kaya et al.|Nature Communications|2025Cited by 0